Posted by Michael Wonder on 01 Apr 2020
PHARMAC widens funding for lenalidomide for those with blood cancer
1 April 2020 - Emma Holden was devastated when she learned she had multiple myeloma.
The 31-year-old, who lives in South Canterbury, was diagnosed with the form of blood cancer in June last year. When she first was told of the cancer she hadn't heard of it before.
She had heard about the drug lenalidomide, used to treat multiple myeloma, from international cases but she knew it wasn't funded here. Access would mean forking out about $100,000 a year.
